Palbociclib Appears to Prolong Progression Free Survival in Women with Metastatic Breast Cancer

As for 10 months of PFS, that’s valuable. Imagine that you’re 55 years old and living with metastatic breast cancer. A drug that is likely to delay, by most of 2 years, your tumor’s expansion into the lungs …A concern I have is that this study wasn’t blinded,

EMILIA Trial: T-DM1 Appears Helpful in Women with Her2+ Metastatic Breast Cancer

The new agent is a hybrid of an old monoclonal antibody, Herceptin, that’s chemically attached to DM1, a traditional kind of chemotherapy. The preliminary results of this randomized trial are encouraging. …It’s hard to know how this promising, likely expensive, intravenous drug will fit in with others for patients with Her2+ breast cancer.

newsletter software